In User Fee Talks, FDA Investigates Pre-market Review Delays
This article was originally published in The Gray Sheet
Executive Summary
As FDA user fee negotiations move ahead, the agency is conducting a root cause analysis to determine why the time it takes to complete pre-market device reviews is increasing.